A13308 Switching from an angiotensin II receptor blocker to azilsartan improved health-related QOL scores beyond sufficient blood pressure-lowering in patients with uncontrolled hypertension

2018 ◽  
Vol 36 ◽  
pp. e327
Author(s):  
Atsushi Tanaka ◽  
Koichi Node
Keyword(s):  
Blood Pressure ◽  
Angiotensin Ii ◽  
Receptor Blocker ◽  
Uncontrolled Hypertension ◽  
Angiotensin Ii Receptor Blocker ◽  
Blood Pressure Lowering ◽  
Angiotensin Ii Receptor ◽  
Pressure Lowering ◽  
Health Related Qol ◽  
Health Related

scholarly journals Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects

2015 ◽  
Vol 56 (6) ◽  
pp. 656-660 ◽  
Author(s):  
Eiji Yahiro ◽  
Shin-ichiro Miura ◽  
Yasunori Suematsu ◽  
Yoshino Matsuo ◽  
Tadaaki Arimura ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Blood Pressure ◽  
Angiotensin Ii ◽  
Receptor Blocker ◽  
Nitric Oxide Donor ◽  
Blood Pressure Lowering ◽  
Pressure Lowering

scholarly journals Management of Home Blood Pressure by Amlodipine Combined With Angiotensin II Receptor Blocker in Type 2 Diabetes

2012 ◽  
Vol 76 (9) ◽  
pp. 2159-2166 ◽  
Author(s):  
Katsumi Miyauchi ◽  
Tsutomu Yamazaki ◽  
Hirotaka Watada ◽  
Yasushi Tanaka ◽  
Ryuzo Kawamori ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Angiotensin Ii ◽  
Home Blood Pressure ◽  
Receptor Blocker ◽  
Angiotensin Ii Receptor Blocker ◽  
Angiotensin Ii Receptor
Sign in / Sign up

Export Citation Format

Share Document